Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 1, 1995
Expression of the CD44 adhesion molecule in primary and metastatic gynecologic malignancies and their cell linesJ.-H. Lee, Y.-S. Kang, B.-G. Kim, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 5, 2011
Vaginal and pelvic recurrence rates based on vaginal cuff length in patients with cervical cancer who underwent radical hysterectomiesK Kim, S Y Cho, S I Park, et al.
Journal of Clinical Pharmacy and Therapeutics|August 1, 1996
Pharmacokinetics of four metabolites of DA-125, a new anthracycline antineoplastic agent after single and multiple intravenous administration to ratsS D Lee, W I Lee, H J Shim, et al.
International Journal of Clinical Pharmacology and Therapeutics|November 10, 2000
Bioequivalence assessment of closerin capsule to dura seromycin capsule of cycloserine after a single oral dose administration to healthy male volunteersY G Kim, Y J Lee, E D Lee, et al.
Cancer Genetics and Cytogenetics|January 1, 1995
Loss of heterozygosity on the short arm of chromosome 17 in uterine cervical carcinomasS Y Park, Y S Kang, B G Kim, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 1, 1994
p53 gene mutation is rare in human cervical carcinomas with positive HPV sequencesJ.-H. Lee, Y.-S. Kang, J.-W. Koh, et al.
Cancer|September 1, 1995
Phase I/II study of neoadjuvant intraarterial chemotherapy with mitomycin-C, vincristine, and cisplatin in patients with stage IIb bulky cervical carcinomaS Y Park, B G Kim, J H Kim, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 25, 2003
Comparative bioavailability of silibinin in healthy male volunteersY C Kim, E J Kim, E D Lee, et al.
Cancer Genetics and Cytogenetics|November 1, 1995
p53 mutation in epithelial ovarian carcinoma and borderline ovarian tumorJ H Lee, Y S Kang, S Y Park, et al.
Gynecologic Oncology|October 1, 1996
Relationship between squamous cell carcinoma antigen levels and tumor volumes in patients with cervical carcinomas undergoing neoadjuvant chemotherapyB G Kim, J H Kim, S Y Park, et al.
Pageof 3